Rontamil Symbio concept Webinar: The most common gastrointestinal disorders in infants and their effective treatment

At Rontis, remaining faithful to our commitment for continuous education, especially during the unprecedented period due to the COVID19 pandemic, we conducted a scientific webinar in order to sustain our traditionally strong corroboration with Healthcare Professionals.

The webinar was co-organized by Rontis, ELPEN Pharmaceuticals, our local partner in Greece, and with the support of the Everest Agency and was held on Saturday November 28th, 2020.

The Rontamil webinar covered the latest updates on the prevalence of gastrointestinal disorders in infants and their nutritional treatment with the enriched with pre-and probiotics Rontamil infant formulas.

Both speakers invited, Dr. Panagiota Kafritsa MD, PHD and Prof. Dr. Yvan Vandenplas, Head of Pediatric Department, University Hospital Brussels, Belgium presented the most common gastrointestinal disorders in infants and their effective treatment with Rontamil infant formulas which offer complete nutrition to non-breastfed infants.

Professor Vandenplas elaborated on the clinical studies performed with Rontis’ products Rontamil Complete 1, Rontamil Complete AC and Rontamil Complete Tr, which clearly proved the safety and showed the superior efficacy of the Rontamil infant formulas as compared to studies previously published in international literature.

Rontis Nutrition commits to stay faithful to its mission to continuously educate the Healthcare community in all subjects related to infant and baby nutrition. With this fundamental principle, we aim to organise more scientific webinars covering more relevant issues as well as inviting Healthcare Professionals of more regions in which we are active in.

Webinar link: https://vimeo.com/529265100

Enjoy!